667 related articles for article (PubMed ID: 19462415)
1. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
Brutti P; De Santis F; Gubbiotti S
Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
[TBL] [Abstract][Full Text] [Related]
2. Bayesian sample size calculations in phase II clinical trials using informative conjugate priors.
Mayo MS; Gajewski BJ
Control Clin Trials; 2004 Apr; 25(2):157-67. PubMed ID: 15020034
[TBL] [Abstract][Full Text] [Related]
3. Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.
Brannath W; Zuber E; Branson M; Bretz F; Gallo P; Posch M; Racine-Poon A
Stat Med; 2009 May; 28(10):1445-63. PubMed ID: 19266565
[TBL] [Abstract][Full Text] [Related]
4. Sample size reestimation by Bayesian prediction.
Wang MD
Biom J; 2007 Jun; 49(3):365-77. PubMed ID: 17623342
[TBL] [Abstract][Full Text] [Related]
5. Empirical Bayes models of Poisson clinical trials and sample size determination.
Zaslavsky BG
Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
[TBL] [Abstract][Full Text] [Related]
6. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
[TBL] [Abstract][Full Text] [Related]
7. Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Yin G; Li Y; Ji Y
Biometrics; 2006 Sep; 62(3):777-84. PubMed ID: 16984320
[TBL] [Abstract][Full Text] [Related]
8. Sample size determination for phase II clinical trials based on Bayesian decision theory.
Stallard N
Biometrics; 1998 Mar; 54(1):279-94. PubMed ID: 9544522
[TBL] [Abstract][Full Text] [Related]
9. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
Kikuchi T; Gittins J
Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
[TBL] [Abstract][Full Text] [Related]
10. The choice of sample size: a mixed Bayesian / frequentist approach.
Pezeshk H; Nematollahi N; Maroufy V; Gittins J
Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
[TBL] [Abstract][Full Text] [Related]
11. Bayesian decision sequential analysis with survival endpoint in phase II clinical trials.
Zhao L; Woodworth G
Stat Med; 2009 Apr; 28(9):1339-52. PubMed ID: 19226557
[TBL] [Abstract][Full Text] [Related]
12. Robust Bayesian sample size determination in clinical trials.
Brutti P; De Santis F; Gubbiotti S
Stat Med; 2008 Jun; 27(13):2290-306. PubMed ID: 18205170
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian predictive strategy for an adaptive two-stage design in phase II clinical trials.
Sambucini V
Stat Med; 2010 Jun; 29(13):1430-42. PubMed ID: 20099246
[TBL] [Abstract][Full Text] [Related]
14. Continual reassessment method: a likelihood approach.
O'Quigley J; Shen LZ
Biometrics; 1996 Jun; 52(2):673-84. PubMed ID: 8672707
[TBL] [Abstract][Full Text] [Related]
15. A seamless phase II/III design with sample-size re-estimation.
Bischoff W; Miller F
J Biopharm Stat; 2009 Jul; 19(4):595-609. PubMed ID: 20183428
[TBL] [Abstract][Full Text] [Related]
16. Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.
Kimani PK; Glimm E; Maurer W; Hutton JL; Stallard N
Stat Med; 2012 Aug; 31(19):2068-85. PubMed ID: 22437262
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian predictive two-stage design for phase II clinical trials.
Sambucini V
Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
[TBL] [Abstract][Full Text] [Related]
18. A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety.
Kikuchi T; Gittins J
Stat Med; 2009 Aug; 28(18):2293-306. PubMed ID: 19536745
[TBL] [Abstract][Full Text] [Related]
19. Bayesian sample size determination in non-sequential clinical trials: Statistical aspects and some regulatory considerations.
Grouin JM; Coste M; Bunouf P; Lecoutre B
Stat Med; 2007 Nov; 26(27):4914-24. PubMed ID: 17559054
[TBL] [Abstract][Full Text] [Related]
20. A semiparametric Bayesian approach to the random effects model.
Kleinman KP; Ibrahim JG
Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]